Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
Washington, DC. – The Advanced Medical Technology Association (AdvaMed) and RCT Ventures announce that the 2015 finals of the MedTech Innovator competition, which identifies and rewards outstanding early-stage medical device companies, will take place at AdvaMed 2015: The MedTech Conference, … Learn more